/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

Y

Yasushi Shimizu

Sapporo Medical University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

216

Papers

5.1K

Citations

27

h-index

45

i10-index

Yasushi Shimizu is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Hearing Loss and Rehabilitation & Head and Neck Cancer Studies & Lung Cancer Treatments and Mutations. The author has an h-index of 27, co-authored 184 publications.

ORCID: 0000-0003-2624-4305

Research Topics

Hearing Loss and Rehabilitation Head and Neck Cancer Studies Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Acoustic Wave Phenomena Research

Papers by this author

works

Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant

2008 · British Journal of Cancer · 33 citations

https://doi.org/10.1038/sj.bjc.6604267

Yasushi Shimizu Ichiro Kinoshita Junko Kikuchi K Yamazaki

Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study

2021 · International Journal of Clinical Oncology · 21 citations

https://doi.org/10.1007/s10147-021-02047-y

Ryuji Yasumatsu Yasushi Shimizu Nobuhiro Hanai Shin Kariya

Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors

2008 · BMC Cancer · 19 citations

https://doi.org/10.1186/1471-2407-8-328

Kayoko Takeda Ichiro Kinoshita Yasushi Shimizu Yusuke Ohba

First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048

2022 · International Journal of Clinical Oncology · 17 citations

https://doi.org/10.1007/s10147-022-02233-6

Shunji Takahashi Nobuhiko Oridate Kaoru Tanaka Yasushi Shimizu

A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)

2020 · Medicine · 12 citations

https://doi.org/10.1097/md.0000000000021457

Kenta Takahashi Eri Ishibashi Toshio Kubo Yohei Harada

First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048

2024 · International Journal of Clinical Oncology · 8 citations

https://doi.org/10.1007/s10147-024-02632-x

Nobuhiko Oridate Shunji Takahashi Kaoru Tanaka Yasushi Shimizu

Research topics

topics

Hearing Loss and Rehabilitation

Head and Neck Cancer Studies

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

Acoustic Wave Phenomena Research

Chat about Author

Papers

Chat

Click to start Chat